These characteristics correlated with their resistance to treatment with birinapant alone and lesser sensitivity with the combination of the death agonists TNF-α when compared with HPV(−) HNSCC cells with FADD amplification (Fig. 4). The gene discussed is FADD; the disease is head and neck squamous cell carcinoma.